Is a regimen of 100 mg progesterone and 1 mg estrogen a common dose for an adult female patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, 100mg progesterone and 1mg estrogen is a common and guideline-supported dose for menopausal hormone therapy

This regimen of 1mg oral estradiol combined with 100mg micronized progesterone daily represents a standard, evidence-based dosing strategy for postmenopausal women with an intact uterus. This combination is explicitly listed in major endocrinology guidelines as a common choice for continuous combined hormone therapy 1.

Guideline-Supported Dosing

The American Association of Clinical Endocrinologists (AACE) guidelines specifically identify micronized progesterone at 100mg daily or 200mg for 10-12 days per month as a common choice for endometrial protection 1. For estrogen, the guidelines list micronized 17β-estradiol at 0.5 to 1mg as a standard oral dose 1.

The Endocrine Society guidelines similarly recommend starting with lower doses than those used in the Women's Health Initiative, with the overarching principle being to use the lowest effective dose 2. Your patient's 1mg estradiol dose falls within this recommended range.

Evidence for Endometrial Protection

The 100mg daily progesterone dose has been extensively validated for endometrial protection. Multiple studies demonstrate that this dose:

  • Efficiently protects the endometrium by fully inhibiting mitoses 3
  • Induces amenorrhea in 91-93% of women by 3-6 months 3
  • Results in no cases of endometrial hyperplasia when combined with estradiol 4, 3
  • Produces serum progesterone levels of 0.39-0.66 ng/mL, which are sufficient to counteract estrogen's endometrial effects 4

Clinical Context

This dosing is appropriate for:

  • Continuous combined therapy: Both hormones taken daily without breaks, which is the most common modern approach to minimize bleeding
  • Women with intact uterus: The progesterone is essential for endometrial protection
  • Symptomatic relief: The 1mg estradiol dose effectively treats vasomotor symptoms while remaining lower than historical doses

Important Caveats

The principle is "one dose does not fit all" 1. While this is a common starting dose, adjustments may be needed based on:

  • Symptom control: If vasomotor symptoms persist, the estradiol dose can be increased
  • Side effects: Some women experience progesterone-related symptoms (mood changes, bloating) and may benefit from switching formulations or routes 1
  • Individual factors: Women with surgical menopause or premature ovarian insufficiency often require higher starting doses (e.g., 100μg transdermal estradiol) 2
  • BMI considerations: Higher BMI may affect endometrial thickness, though recent data suggests progesterone dose should be clinically guided rather than automatically increased 5

Do not use FSH levels to monitor adequacy of estrogen dosing - this is inappropriate as estrogen is not the only regulator of FSH secretion 1.

The regimen your patient is on represents standard, evidence-based practice supported by multiple professional society guidelines 1.

References

1
Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

2
Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Related Questions

In a 54-year-old woman using Bi‑Est (transdermal estriol/estradiol) 2.5 mg daily (80 % estriol/20 % estradiol) and oral micronized progesterone 50 mg daily, can this regimen cause spotting?
What is the appropriate dosing regimen for compounded oral micronized progesterone and estradiol cream in hormone therapy?
For a 53-year-old woman on hormone replacement therapy using a transdermal estradiol patch (0.0375% concentration) applied twice weekly continuously and oral micronized progesterone 100 mg daily for two weeks each month, is this regimen appropriate and what follow‑up monitoring or adjustments should be considered?
What are the consequences of a 55‑year‑old woman with an intact uterus taking two daily 100 mg Prometrium (micronized progesterone) capsules instead of the prescribed one while on Oestrogel (estradiol) transdermal hormone replacement therapy?
How should intermittent (cyclical) progesterone be dosed in hormone replacement therapy for a woman with an intact uterus receiving estrogen?
What next analgesic medication is appropriate for a patient with ongoing bilateral knee pain who has tried acetaminophen (Tylenol) and physical therapy without relief and has no recent trauma?
What should a patient being evaluated for adrenal insufficiency do or avoid in the two weeks before cortisol, aldosterone, and renin testing to ensure accurate results?
Is hepatitis B vaccination indicated for a healthy 45-year-old man who has not been previously immunized?
What transdermal estradiol and progesterone patch options are available for a dose equivalent to 1 mg oral estradiol and 100 mg oral progesterone?
What is the recommended treatment for invasive Salmonella infection?
What is Rexulti (brexpiprazole)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.